[Biphosphonates and osteonecrosis].
Irani
Jacques
J
Service d'Urologie, Hôpital de la Milétrie, Poitiers, France.
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008439:Maxillary Diseases / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000473:pathology; D010020:Osteonecrosis / Q000139:chemically induced*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates